1. Home
  2. GKOS vs GGAL Comparison

GKOS vs GGAL Comparison

Compare GKOS & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • GGAL
  • Stock Information
  • Founded
  • GKOS 1998
  • GGAL 1905
  • Country
  • GKOS United States
  • GGAL Argentina
  • Employees
  • GKOS N/A
  • GGAL N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • GGAL Commercial Banks
  • Sector
  • GKOS Health Care
  • GGAL Finance
  • Exchange
  • GKOS Nasdaq
  • GGAL Nasdaq
  • Market Cap
  • GKOS 8.4B
  • GGAL 9.2B
  • IPO Year
  • GKOS 2015
  • GGAL N/A
  • Fundamental
  • Price
  • GKOS $156.36
  • GGAL $67.07
  • Analyst Decision
  • GKOS Strong Buy
  • GGAL Strong Buy
  • Analyst Count
  • GKOS 13
  • GGAL 4
  • Target Price
  • GKOS $147.23
  • GGAL $59.00
  • AVG Volume (30 Days)
  • GKOS 662.3K
  • GGAL 1.1M
  • Earning Date
  • GKOS 02-19-2025
  • GGAL 01-01-0001
  • Dividend Yield
  • GKOS N/A
  • GGAL 3.54%
  • EPS Growth
  • GKOS N/A
  • GGAL 32.62
  • EPS
  • GKOS N/A
  • GGAL 0.56
  • Revenue
  • GKOS $360,347,000.00
  • GGAL $4,434,816,496.00
  • Revenue This Year
  • GKOS $22.69
  • GGAL N/A
  • Revenue Next Year
  • GKOS $26.76
  • GGAL N/A
  • P/E Ratio
  • GKOS N/A
  • GGAL $13.45
  • Revenue Growth
  • GKOS 18.70
  • GGAL N/A
  • 52 Week Low
  • GKOS $83.90
  • GGAL $16.65
  • 52 Week High
  • GKOS $161.13
  • GGAL $74.00
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.10
  • GGAL 52.20
  • Support Level
  • GKOS $142.71
  • GGAL $67.24
  • Resistance Level
  • GKOS $158.01
  • GGAL $72.51
  • Average True Range (ATR)
  • GKOS 4.96
  • GGAL 3.30
  • MACD
  • GKOS -0.16
  • GGAL -0.33
  • Stochastic Oscillator
  • GKOS 74.10
  • GGAL 42.11

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About GGAL Grupo Financiero Galicia S.A.

Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.

Share on Social Networks: